Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-13 Option Award |
2023-02-15 4:47 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
16,720 | $0 | 16,720 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
1,127 | $44.16 | 145,553 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:11 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
3,375 | $0 | 145,553 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:42 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
13,300 | $0 | 13,300 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-21 4:03 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
3,800 | $0 | 142,619 (Direct) |
View |
| 2021-10-19 Tax Withholding |
2021-10-21 4:03 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
1,116 | $40.29 | 142,619 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-17 09:12 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
4,000 | $0 | 139,651 (Direct) |
View |
| 2021-06-15 Tax Withholding |
2021-06-17 09:12 am |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
1,144 | $58.8 | 139,651 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 4:02 pm |
N/A 2031-02-10 |
Sage Therapeutics Inc. | SAGE | Robichaud Albert Chief Scientific Officer |
22,500 | $0 | 22,500 (Direct) |
View |